The FDA's slowness on a COVID vaccine isn't the issue
The U.S. Food and Drug Administration's meeting to evaluate whether the Pfizer-BioNTech vaccine should be authorized for emergency use is scheduled for Thursday, but it's already c…
The U.S. Food and Drug Administration's meeting to evaluate whether the Pfizer-BioNTech vaccine should be authorized for emergency use is scheduled for Thursday, but it's already c…